• MG Outcome Measures Effectively Reflect Rapid Improvements After Plasma Exchange, Study Shows
  • I Was Honored to Receive an Award for My Rare Disease Advocacy
  • UCB Buys Ra Pharma, Adding Zilucoplan to Its MG Pipeline
  • NIH Grants $7.8M to Support Launch of Rare Disease Network for Myasthenia Gravis
  • First Patient Dosed in Phase 3 Trial of Zilucoplan, Ra Pharma Announces
  • Certain Medications and Smoking Cessation Can Protect Ocular MG From Becoming Generalized, Study Says
  • NORD 2019 Rare Disease Summit Set for Oct. 21-22 in Washington, DC
  • DAS Therapeutics Acquires Full Rights to GT Biopharma’s Oral Therapy GTP-004
  • Reassessing What’s Important After Relapse
  • Long-Term Use of Gabapentin May Trigger MG Exacerbations, Case Report Says
  • Diabetes Drug Metformin Reduces Clinical Severity of Myasthenia Gravis in Animal Study
  • Recording Eye Movements May Help Diagnose MG Earlier, Study Suggests